Corporate perspectives: Roche on the satisfactions of early gpi adoption
Martin Schlageter, head of treasury operations at Roche, the pharmaceutical company based in Switzerland, gives TXF his candid take on SWIFT gpi developments and the corporate experience of financing trade in challenging times.
Hello stranger, fancy seeing you here…
Unfortunately you’ve stumbled across our paid-for content but that’s not a problem, join the TXF Essentials community today for unrestricted access to:
- Daily news and analysis from our TXF experts
- Access to TXF data dashboards and Smart Search
- Market reports and bi-annual long reads
- And much much more…
Sign in to post a comment. If you don't have an account register here.